- conflicts or gaps
- [[{"field": {"value": "funding.rounds[Series A].amount_usd", "source_urls": ["https://www.businesswire.com/news/home/20170906005569/en/Notable-Labs-Raises-10-Million-Series-Financing", "https://venturebeat.com/business/notable-raises-50-million-to-personalize-cancer-drug-regimens"]}, "issue": {"value": "Business Wire and BioCentury report $10M Series A (Sep 2017); VentureBeat (Jul 2019) incorrectly cites $14.8M Series A.", "source_urls": ["https://www.businesswire.com/news/home/20170906005569/en/Notable-Labs-Raises-10-Million-Series-Financing", "https://venturebeat.com/business/notable-raises-50-million-to-personalize-cancer-drug-regimens"]}, "source_urls": ["https://www.businesswire.com/news/home/20170906005569/en/Notable-Labs-Raises-10-Million-Series-Financing", "https://venturebeat.com/business/notable-raises-50-million-to-personalize-cancer-drug-regimens"]}, {"field": {"value": "identity.current_status", "source_urls": ["https://www.ycombinator.com/companies/notable-labs", "https://www.bankruptcyobserver.com/bankruptcy-case/notable-labs"]}, "issue": {"value": "YC profile still lists status 'Public' and active job postings; company filed Chapter 7 bankruptcy Oct 2024 and ceased operations.", "source_urls": ["https://www.ycombinator.com/companies/notable-labs", "https://www.bankruptcyobserver.com/bankruptcy-case/notable-labs", "https://www.fiercebiotech.com/biotech/notable-labs-files-bankruptcy-ending-ambitions-boehringer-cancer-drug"]}, "source_urls": ["https://www.ycombinator.com/companies/notable-labs", "https://www.bankruptcyobserver.com/bankruptcy-case/notable-labs"]}, {"field": {"value": "exit_status.bankruptcy_chapter", "source_urls": ["https://www.marketscreener.com/quote/stock/NOTABLE-LABS-LTD-17053959/news/Notable-Labs-Inc-Filed-for-Bankruptcy-48065675/", "https://www.bankruptcyobserver.com/bankruptcy-case/notable-labs"]}, "issue": {"value": "MarketScreener initially reported Chapter 11; court docket and BankruptcyObserver confirm Chapter 7 voluntary liquidation.", "source_urls": ["https://www.marketscreener.com/quote/stock/NOTABLE-LABS-LTD-17053959/news/Notable-Labs-Inc-Filed-for-Bankruptcy-48065675/", "https://www.bankruptcyobserver.com/bankruptcy-case/notable-labs", "https://www.pacermonitor.com/public/case/55442113/Notable_Labs,_Ltd"]}, "source_urls": ["https://www.marketscreener.com/quote/stock/NOTABLE-LABS-LTD-17053959/news/Notable-Labs-Inc-Filed-for-Bankruptcy-48065675/", "https://www.bankruptcyobserver.com/bankruptcy-case/notable-labs"]}, {"field": {"value": "exit_status.assets_at_bankruptcy", "source_urls": ["https://www.bankruptcyobserver.com/bankruptcy-case/notable-labs", "https://www.marketscreener.com/quote/stock/NOTABLE-LABS-LTD-17053959/news/Notable-Labs-Inc-Filed-for-Bankruptcy-48065675/"]}, "issue": {"value": "Bankruptcy petition checkbox range lists assets $0–$100K; filed schedules summarized by MarketScreener as $5.80M assets and $2.59M liabilities.", "source_urls": ["https://www.bankruptcyobserver.com/bankruptcy-case/notable-labs", "https://www.marketscreener.com/quote/stock/NOTABLE-LABS-LTD-17053959/news/Notable-Labs-Inc-Filed-for-Bankruptcy-48065675/"]}, "source_urls": ["https://www.bankruptcyobserver.com/bankruptcy-case/notable-labs", "https://www.marketscreener.com/quote/stock/NOTABLE-LABS-LTD-17053959/news/Notable-Labs-Inc-Filed-for-Bankruptcy-48065675/"]}, {"field": {"value": "products[second clinical-stage candidate]", "source_urls": ["https://www.sec.gov/Archives/edgar/data/1603207/000149315223005823/ex99-1.htm", "https://www.globenewswire.com/news-release/2023/10/16/2760962/0/en/Notable-Labs-Closes-Merger-Transaction-With-VBL-Therapeutics.html"]}, "issue": {"value": "Merger materials state PPMP guided selection of two clinical-stage therapeutic candidates in AML, but only volasertib is publicly named; identity of second candidate not disclosed in reviewed sources.", "source_urls": ["https://www.sec.gov/Archives/edgar/data/1603207/000149315223005823/ex99-1.htm", "https://www.globenewswire.com/news-release/2023/10/16/2760962/0/en/Notable-Labs-Closes-Merger-Transaction-With-VBL-Therapeutics.html"]}, "source_urls": ["https://www.sec.gov/Archives/edgar/data/1603207/000149315223005823/ex99-1.htm", "https://www.globenewswire.com/news-release/2023/10/16/2760962/0/en/Notable-Labs-Closes-Merger-Transaction-With-VBL-Therapeutics.html"]}, {"field": {"value": "employees.count (post-2020)", "source_urls": ["https://www.ycombinator.com/companies/notable-labs", "https://builtin.com/company/notable", "https://www.linkedin.com/company/notable-labs"]}, "issue": {"value": "Post-2019 headcount not consistently reported; third-party directories cite 8–45 employees with stale/conflicting data; only ~65% RIF (Sep 2024) and bankruptcy departure confirmed.", "source_urls": ["https://www.ycombinator.com/companies/notable-labs", "https://builtin.com/company/notable", "https://www.linkedin.com/company/notable-labs", "https://www.sec.gov/Archives/edgar/data/1603207/000149315224037122/form8-k.htm"]}, "source_urls": ["https://www.ycombinator.com/companies/notable-labs", "https://www.sec.gov/Archives/edgar/data/1603207/000149315224037122/form8-k.htm"]}, {"field": {"value": "products[volasertib license chain]", "source_urls": ["https://www.businesswire.com/news/home/20211111005536/en/Notable-Launches-Therapeutic-Pipeline-by-Acquiring-Worldwide-Development-and-Commercialization-Rights-to-Volasertib", "https://www.fiercebiotech.com/biotech/notable-labs-files-bankruptcy-ending-ambitions-boehringer-cancer-drug"]}, "issue": {"value": "Primary license press release states Notable obtained rights from Oncoheroes Biosciences (which in-licensed from Boehringer Ingelheim); some later press shorthand says licensed directly from Boehringer.", "source_urls": ["https://www.businesswire.com/news/home/20211111005536/en/Notable-Launches-Therapeutic-Pipeline-by-Acquiring-Worldwide-Development-and-Commercialization-Rights-to-Volasertib", "https://www.fiercebiotech.com/biotech/notable-labs-files-bankruptcy-ending-ambitions-boehringer-cancer-drug"]}, "source_urls": ["https://www.businesswire.com/news/home/20211111005536/en/Notable-Launches-Therapeutic-Pipeline-by-Acquiring-Worldwide-Development-and-Commercialization-Rights-to-Volasertib", "https://www.fiercebiotech.com/biotech/notable-labs-files-bankruptcy-ending-ambitions-boehringer-cancer-drug"]}, {"field": {"value": "identity.hq_location (early years)", "source_urls": ["https://techcrunch.com/2015/03/10/yc-backed-notable-labs-provides-personalized-medical-testing-for-brain-cancer-patients/", "https://www.businesswire.com/news/home/20170906005569/en/Notable-Labs-Raises-10-Million-Series-Financing"]}, "issue": {"value": "Early sources list San Francisco/SOMA lab; later sources and current HQ consistently Foster City, CA.", "source_urls": ["https://techcrunch.com/2015/03/10/yc-backed-notable-labs-provides-personalized-medical-testing-for-brain-cancer-patients/", "https://www.businesswire.com/news/home/20170906005569/en/Notable-Labs-Raises-10-Million-Series-Financing", "https://www.ycombinator.com/companies/notable-labs"]}, "source_urls": ["https://techcrunch.com/2015/03/10/yc-backed-notable-labs-provides-personalized-medical-testing-for-brain-cancer-patients/", "https://www.ycombinator.com/companies/notable-labs"]}]]
- source urls
- ["https://builtin.com/company/notable", "https://connectedsocialmedia.com/18085/tech-tonics-matthew-de-silva-ceo-founder-of-notable-labs/", "https://golden.com/wiki/Peter_Quinzio-MN4XNXG", "https://linkedin.com/in/matthewdesilva", "https://me.sh/profile/peter-quinzio", "https://medcitynews.com/2017/09/notable-labs-raises-10m-cancer-testing-service-develop-therapeutic-index-clinicians/", "https://medcitynews.com/2019/07/personalized-cancer-treatment-startup-notable-labs-nabs-40-million-series-b/", "https://notablelabs.com/", "https://techcrunch.com/2015/03/10/yc-backed-notable-labs-provides-personalized-medical-testing-for-brain-cancer-patients/", "https://venturebeat.com/business/notable-raises-50-million-to-personalize-cancer-drug-regimens", "https://www.bankruptcyobserver.com/bankruptcy-case/notable-labs", "https://www.biocentury.com/article/289336/notable-labs-raises-10m-in-series-a", "https://www.businesswire.com/news/home/20170906005569/en/Notable-Labs-Raises-10-Million-Series-Financing", "https://www.businesswire.com/news/home/20211111005536/en/Notable-Launches-Therapeutic-Pipeline-by-Acquiring-Worldwide-Development-and-Commercialization-Rights-to-Volasertib", "https://www.einpresswire.com/article/490804163/notable-announces-40m-series-b-round-to-fuel-development-of-its-drug-discovery-platform-for-personalized-oncology", "https://www.fiercebiotech.com/biotech/notable-labs-files-bankruptcy-ending-ambitions-boehringer-cancer-drug", "https://www.gaebler.com/VC-Funding-14238C7C-2C85-4E99-BAA3-1F9C9D27671D-Notable-03-24-2015", "https://www.globenewswire.com/news-release/2023/10/16/2760962/0/en/Notable-Labs-Closes-Merger-Transaction-With-VBL-Therapeutics.html", "https://www.globenewswire.com/news-release/2024/02/22/2833635/0/en/Notable-Advances-Volasertib-Phase-2-Program-Utilizing-Proprietary-Predictive-Precision-Medicine-Platform-Guided-Enrollment.html", "https://www.globenewswire.com/news-release/2024/08/26/2935803/0/en/Notable-Labs-Announces-CEO-Transition.html", "https://www.intelligence360.news/notable-labs-has-filed-a-notice-of-an-exempt-offering-of-securities-to-raise-10336259-00-in-new-equity-investment/", "https://www.investing.com/news/company-news/notable-labs-files-for-bankruptcy-board-resigns-93CH-3664344", "https://www.linkedin.com/company/notable-labs", "https://www.marketscreener.com/quote/stock/NOTABLE-LABS-LTD-17053959/news/Notable-Labs-Inc-Filed-for-Bankruptcy-48065675/", "https://www.newswire.com/news/notable-names-dr-thomas-a-bock-as-ceo-21354508", "https://www.pacermonitor.com/public/case/55442113/Notable_Labs,_Ltd", "https://www.sec.gov/Archives/edgar/data/1603207/000149315223005823/ex99-1.htm", "https://www.sec.gov/Archives/edgar/data/1603207/000149315224037122/form8-k.htm", "https://www.sec.gov/Archives/edgar/data/1603207/000149315224041006/0001493152-24-041006-index.htm", "https://www.ycombinator.com/companies/notable-labs", "https://www.ycombinator.com/companies/notable-labs/jobs/ti2HBnyyd-product-development-scientist-senior-assay-development-scientist"]